126 related articles for article (PubMed ID: 16412021)
1. Autoantibodies to thrombin directed against both of its cryptic exosites.
Mollica L; Preston RJ; Chion AC; Lees SJ; Collins P; Lewis S; Lane DA
Br J Haematol; 2006 Feb; 132(4):487-93. PubMed ID: 16412021
[TBL] [Abstract][Full Text] [Related]
2. The effects of exosite occupancy on the substrate specificity of thrombin.
Ng NM; Quinsey NS; Matthews AY; Kaiserman D; Wijeyewickrema LC; Bird PI; Thompson PE; Pike RN
Arch Biochem Biophys; 2009 Sep; 489(1-2):48-54. PubMed ID: 19638274
[TBL] [Abstract][Full Text] [Related]
3. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
Arocas V; Zingali RB; Guillin MC; Bon C; Jandrot-Perrus M
Biochemistry; 1996 Jul; 35(28):9083-9. PubMed ID: 8703912
[TBL] [Abstract][Full Text] [Related]
4. Polyphosphate binds with high affinity to exosite II of thrombin.
Mutch NJ; Myles T; Leung LL; Morrissey JH
J Thromb Haemost; 2010 Mar; 8(3):548-55. PubMed ID: 20002544
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of thrombin-catalyzed factor V activation by bothrojaracin.
Arocas V; Lemaire C; Bouton MC; Bezeaud A; Bon C; Guillin MC; Jandrot-Perrus M
Thromb Haemost; 1998 Jun; 79(6):1157-61. PubMed ID: 9657441
[TBL] [Abstract][Full Text] [Related]
6. Surface plasmon resonance spectroscopy study of interfacial binding of thrombin to antithrombin DNA aptamers.
Tang Q; Su X; Loh KP
J Colloid Interface Sci; 2007 Nov; 315(1):99-106. PubMed ID: 17689549
[TBL] [Abstract][Full Text] [Related]
7. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II.
Monteiro RQ; Rapôso JG; Wisner A; Guimarães JA; Bon C; Zingali RB
Biochem Biophys Res Commun; 1999 Sep; 262(3):819-22. PubMed ID: 10471408
[TBL] [Abstract][Full Text] [Related]
8. Thrombin specificity.
Guillin MC; Bezeaud A; Bouton MC; Jandrot-Perrus M
Thromb Haemost; 1995 Jul; 74(1):129-33. PubMed ID: 8578445
[TBL] [Abstract][Full Text] [Related]
9. Beta2-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta2-glycoprotein I antibodies potentiate the inhibitory effect of beta2-glycoprotein I on thrombin-mediated factor XIa generation.
Rahgozar S; Yang Q; Giannakopoulos B; Yan X; Miyakis S; Krilis SA
Arthritis Rheum; 2007 Feb; 56(2):605-13. PubMed ID: 17265495
[TBL] [Abstract][Full Text] [Related]
10. Bivalent binding to gammaA/gamma'-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex.
Fredenburgh JC; Stafford AR; Leslie BA; Weitz JI
J Biol Chem; 2008 Feb; 283(5):2470-7. PubMed ID: 18055456
[TBL] [Abstract][Full Text] [Related]
11. Activation-induced exposure of the thrombin anion-binding exosite. Interactions of recombinant mutant prothrombins with thrombomodulin and a thrombin exosite-specific antibody.
Wu Q; Picard V; Aiach M; Sadler JE
J Biol Chem; 1994 Feb; 269(5):3725-30. PubMed ID: 8106418
[TBL] [Abstract][Full Text] [Related]
12. Allosteric effects of a monoclonal antibody against thrombin exosite II.
Colwell NS; Blinder MA; Tsiang M; Gibbs CS; Bock PE; Tollefsen DM
Biochemistry; 1998 Oct; 37(43):15057-65. PubMed ID: 9790668
[TBL] [Abstract][Full Text] [Related]
13. An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme.
Sié P; Bezeaud A; Dupouy D; Archipoff G; Freyssinet JM; Dugoujon JM; Serre G; Guillin MC; Boneu B
J Clin Invest; 1991 Jul; 88(1):290-6. PubMed ID: 1711542
[TBL] [Abstract][Full Text] [Related]
14. Evidence for allosteric linkage between exosites 1 and 2 of thrombin.
Fredenburgh JC; Stafford AR; Weitz JI
J Biol Chem; 1997 Oct; 272(41):25493-9. PubMed ID: 9325262
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous occurrence of human antibodies directed against fibrinogen, thrombin, and factor V following exposure to bovine thrombin: effects on blood coagulation, protein C activation and platelet function.
Chouhan VD; De La Cadena RA; Nagaswami C; Weisel JW; Kajani M; Rao AK
Thromb Haemost; 1997 Feb; 77(2):343-9. PubMed ID: 9157594
[TBL] [Abstract][Full Text] [Related]
16. Role of prothrombin fragment 1 in the pathway of regulatory exosite I formation during conversion of human prothrombin to thrombin.
Anderson PJ; Bock PE
J Biol Chem; 2003 Nov; 278(45):44489-95. PubMed ID: 12939270
[TBL] [Abstract][Full Text] [Related]
17. Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II.
Becker DL; Fredenburgh JC; Stafford AR; Weitz JI
J Biol Chem; 1999 Mar; 274(10):6226-33. PubMed ID: 10037709
[TBL] [Abstract][Full Text] [Related]
18. Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II.
Verhamme IM; Olson ST; Tollefsen DM; Bock PE
J Biol Chem; 2002 Mar; 277(9):6788-98. PubMed ID: 11724802
[TBL] [Abstract][Full Text] [Related]
19. The amino acid sequence in fibrin responsible for high affinity thrombin binding.
Meh DA; Siebenlist KR; Brennan SO; Holyst T; Mosesson MW
Thromb Haemost; 2001 Mar; 85(3):470-4. PubMed ID: 11307817
[TBL] [Abstract][Full Text] [Related]
20. Role of exosites 1 and 2 in thrombin reaction with plasminogen activator inhibitor-1 in the absence and presence of cofactors.
Rezaie AR
Biochemistry; 1999 Nov; 38(44):14592-9. PubMed ID: 10545182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
